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Abstract  We  present  the  case  of  a  58-year-old  male  patient  who  had  symptoms  of  anxiety  after
witnessing a  case  of  social  violence  in  his  community  in  2005.  After  that,  he  presented  symptoms
of Parkinson  Disease  and  in  2006  we  established  this  as  the  main  diagnosis.  In  2009  he  presented
neuropsychiatric  symptoms  such  as  apathy,  anhedonia,  social  isolation,  blunted  affect,  visual
and auditory  hallucinations,  paranoid  delusions,  soliloquies,  and  the  false  belief  that  his  wife
and daughter  had  been  replaced  by  identical  impostors.  We  established  the  diagnosis  of  Capgras
Syndrome. This  case  is  clinically  relevant  because  of  the  presentation  of  its  symptoms,  its
evolution and  its  presenting  comorbidity.
© 2014  Universidad  Autónoma  de  Nuevo  León.  Published  by  Masson  Doyma  México  S.A.  All  rights
reserved.
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(Introduction
The  ability  to  recognize  faces  and  discriminate  those  which
are  not  familiar  to  us  is  there  since  birth,  and  it  is  developed∗ Corresponding author at: Paseo de las Fuentes, No. 4637 Col.
Villa Las Fuentes, Monterrey, Nuevo León, C.P. 64890, Mexico.
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(S.L. Barbosa-Flores).
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1665-5796/© 2014 Universidad Autónoma de Nuevo León. Published by Mnd  perfected  through  the  ﬁrst  years  of  life.  Delusional
isidentiﬁcation  syndromes  are  a  group  of  phenomena  in
hich  patients  erroneously  identify  familiar  people  or  places
r  even  themselves,  believing  said  objects  or  people  to  have
een  replaced  or  transformed.  There  are  several  subtypes,
owever,  most  authors  divide  it  into  4  main  syndromes
Capgras  syndrome,  Frégoli  syndrome,  Intermetamorphosis
yndrome  and  syndrome  of  subjective  doubles),  Capgras
yndrome  being  the  most  common  among  these  syndromes.1
Joseph  Capgras  described  the  ﬁrst  case  of  a  syndrome
haracterized  by  the  delusional  belief  that  a  close  relative
asson Doyma México S.A. All rights reserved.
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as  been  replaced  by  an  impostor.  In  the  beginning,  it  was
elieved  to  be  associated  to  a  higher  degree  with  psychi-
tric  disorders,  but  in  fact  it  is  more  frequently  associated
ith  neurodegenerative  diseases,  especially  with  Lewy  body
isease,  and  it  is  commonly  found  in  association  with  visual
allucinations.2 In  the  case  of  Capgras  syndrome,  there  is
ot  only  the  misidentiﬁcation  of  someone  familiar  to  them,
ut  a  delusional  belief  that  the  person  has  been  replaced  by
 double  that  is  not  quite  exact.  Study  of  the  causes  has  been
losely  linked  to  the  analysis  of  patients  with  brain  injuries
hich  would  have  developed  prosopagnosia.3 This  percep-
ual  disorder  causes  the  patient  to  be  unable  to  recognize
aces  in  a  consistent  way,  despite  the  fact  that  he/she  is
ble  to  recognize  visual  objects.4
Continuing  along  the  lines  of  the  study  of  Capgras  syn-
rome,  starting  from  the  prosopagnosia  phenomenon,  it  has
een  suggested  that  there  would  be  a  ‘‘mirror  image’’  of
rosopagnosia,  in  a  way  that,  although  the  conscious  ability
o  recognize  faces  would  be  intact,  there  would  be  damages
o  the  system  that  produces  automatic  emotional  excite-
ent  when  observing  familiar  faces.5 This  ﬁnding  was  later
onﬁrmed  in  patients  with  a  Capgras  syndrome  diagnosis.
Traditionally,  the  origin  of  Capgras  syndrome  was  consid-
red  to  reside  in  a  psychodynamic  base;  the  premise  was
hat  people  who  received  a  great  deal  of  affection  from  the
atients  were  also  recipients  of  their  ambivalence,  which
ade  them  the  object  of  the  projections  and  led  to  the
atient’s  psychological  disintegration.
On  the  other  hand,  in  addition  to  prosopagnosia,  Capgras
yndrome  has  been  linked  with  multiple  pathologies.  It  has
een  described  in  psychiatric  as  well  as  organic  disorders.
ithin  psychiatric  proﬁles,  it  is  common  to  ﬁnd  this  delusion
n  paranoid  schizophrenia,  as  well  as  psychotic  depression,
elusional  disorders,  schizoaffective  disorder  or  bipolar  dis-
rder,  with  a  frequency  of  1--15%  in  psychotic  patients.
Regarding  the  organic  conditions  that  occur  in  Capgras
elusion,  this  appears  mainly  in  various  types  of  demen-
ia  like  Alzheimer,  Lewy  bodies  and  Parkinson,  as  well  as
osterior  to  brain  injuries.  It  is  followed  among  other  con-
itions  by  ictus,  epilepsy,  chronic  alcoholism  cases  and
ncephalitis.6
Capgras  syndrome  has  been  considered  a  type  of  paranoid
sychosis  more  frequently  linked  to  Lewy  body  dementia,
s  well  as  psychiatric  illnesses  like  schizophrenia.  Neverthe-
ess,  there  are  reports  in  medical  literature  that  even  link  it
o  dopaminergic  deﬁciency,  which  appears  during  the  ‘‘off’’
tates,  solving  it  with  an  increment  in  L-dope  and  less  fre-
uently  in  an  isolated  form  as  a  psychiatric  manifestation
f  Parkinson’s  disease.7 Below,  we  describe  a  peculiar  case
f  a  patient  who  presented  Parkinson’s  disease  and  Capgras
yndrome  simultaneously.
linical case
he  patient  is  a  58-year-old  male  with  a  history  of  systemic
rterial  hypertension  (since  he  was  45  years  old),  without
 history  of  any  other  major  health  issue.  His  symptoms
egan  in  2004  with  a  right  upper  limb  tremor  which  did
ot  affect  his  everyday  life,  and  thus  was  not  given  impor-
ance.  In  2005  he  witnessed  a  situation  of  social  violence
aving  been  caught  in  a  crossﬁre  and  having  his  workplace
o
p
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ttacked  with  a  grenade.  As  a  result,  he  began  displaying  the
ollowing  symptoms:  anxiety,  fear,  recurrent  memories  of
he  event,  affective  bottling,  hypervigilance  and  avoidance
ehavior,  with  a signiﬁcant  decline  in  his  work  and  social
ctivity.  He  was  diagnosed  with  acute  stress  disorder  and
egan  treatment  with  50  mg  of  sertraline  every  24  h,  with  a
emission  of  symptoms.  Subsequently,  other  symptoms  char-
cterized  by  bradykinesia  appeared,  with  an  increase  in  the
ight  upper  limb  rest  tremor,  ﬁne  motor  clumsiness  and  gait
nd  posture  alterations  being  asymmetrical  with  uncoordi-
ated  arm  movement.  A  Parkinson’s  disease  diagnosis  was
stablished  in  2006.  In  2009  the  patient  displayed  neuropsy-
hiatric  signs  and  symptoms,  apathy,  anhedonia,  a  tendency
o  isolation,  affective  bottling,  and  later  aural  and  visual
allucinations  with  paranoid  content,  soliloquies,  as  well
s  a  false  belief  that  his  wife  and  daughter  were  not  them
ut  had  been  replaced  by  other  people,  thus  integrating  a
apgras  syndrome.
The following  clinimetrics  were  performed:  The  Schwab
 England  Activities  of  Daily  Living  Scale,  which  evaluates
he  patient’s  functional  state,  with  a  value  of  10%,  mean-
ng  the  patient  is  ‘‘Totally  dependent,  harmless;  completely
andicapped’’.  Hoehn  and  Yahr  evaluation  scale,  a  descrip-
ive  staging  scale  of  the  progression  of  Parkinson’s  disease
ymptoms,  placing  the  patient  in  a  stage  4:  Severe  dis-
bility;  still  able  to  walk  or  stand  unassisted.  Freezing  and
‘on-off’’  unpredictable  (Stages  1--5,  where  stage  1:  mini-
al  or  no  functional  disability  and  stage  5:  the  patient  is
onﬁned  to  a  bed).  Montreal  Cognitive  Assessment  battery
MoCa)  evaluates  mild  cognitive  impairment,  with  a  score
f  11,  corresponding  to  a  moderate  cognitive  impairment
normal  range  of  24--30).  Hamilton  anxiety  rating  scale  of
0  (mild  anxiety).  Hamilton  depression  scale  with  5  points
not  depressed).  Folstein  Mini-Mental  State  Exam  with  17
oints,  corresponding  to  moderate  impairment.
Treatment  was  begun  with  levodopa/carbidopa
50  mg/25  mg  orally,  ½ pill  every  6  h,  and  amantadine
00  mg  orally  ½ tbsp  every  8  h  with  a  positive  control  of
arkinsonism  symptoms.  Regarding  psychotic  symptoms,
e  began  treatment  with  quetiapine  150  mg  with  positive
esults.  Currently  the  patient  continues  with  the  same
reatment  and  is  stable,  with  good  control  of  Parkinson’s
ymptoms,  in  addition  to  not  presenting  current  active
sychosis.
iscussion and conclusions
he  presence  of  hallucinations  and  delusions  is  frequent
n  Parkinson’s  disease,  affecting  around  20--30%  of  the
atients.8 Psychotic  symptoms  have  been  linked  to  the  dis-
ase  before  there  were  treatments  for  it,  but  its  prevalence
as  considerably  risen  since  the  generalization  of  the  use
f  dopaminergic  stimulation.9 There  also  have  been  reports
f  the  presence  of  transient  neurocognitive  changes,  sec-
ndary  to  the  placement  of  a  deep  cerebral  stimulator  for
esistant  Parkinson’s,  causing  symptoms  characteristic  of
apgras  syndrome.10One  of  the  most  relevant  intrinsic  factors  in  the  devel-
pment  of  psychosis  is  the  cholinergic  deﬁcit.  Other
recipitant  and  risk  factors  linked  to  the  disease  itself
re  the  age  of  onset,  length,  presence  of  depression  and
n’s  d
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especially  the  presence  of  cognitive  impairment,  because
Capgras  syndrome  appears  in  the  later  stages  of  dementia
in  Parkinson’s,  which  results  in  stressing  situations  for  the
patients  and  even  more  for  the  caregivers.11
The  most  important  factor  is  the  direct  and  indirect
stimulation  of  the  corticolimbic  dopaminergic  receptors.
In  fact,  these  phenomena  may  appear  even  in  patients
being  treated  with  L-Dopa  or  dopaminergic  agonists  in  early
stages,  although  its  frequency  increases  considerably  in
more  advanced  patients  and  in  patients  with  complications,
especially  if  they  develop  dementia.  Recent  processing
models  highlight  the  dissociation  between  recognition  and
emotional  response,  based  --  from  the  neurobiological  point
of  view  -- on  the  disconnection  between  the  frontal  lobe
and  the  right  temporal  and  limbic  regions,  along  with
the  bilateral  frontal  damage.  Some  theories  suggest  a
two-way  intervention  as  an  explanation,  one  lateral  non-
cortical  and  the  other  subcortical,  located  in  the  right
hemisphere.12
Evidence  that  not  all  patients  with  right  hemisphere
affectation  develop  a  delusional  syndrome  has  led  to  suggest
the  presence  of  a  positive  mechanism  creator  of  delusions,
which  would  require  at  least  a  certain  preservation  of  the
left  hemisphere.  This  usually  acts  to  inhibit  the  right  side;
it  tries  to  give  coherence  and  sense  and  interpret  dissonant
information  between  recognition  and  absence  of  familiarity,
thus  its  affectation  would  lead  to  delusion.13
Moreover,  the  monothematic  delusion  two-factor  theory,
among  which  there  is  the  Capgras  syndrome,  suggests  that
the  genesis  is  caused  by  a  double  failure:  a  right  hemisphere
injury,  probably  in  the  ventromedial  zone  of  the  right-frontal
lobe,  in  addition  to  the  failure  of  the  beliefs  comparison
mechanism,  which  produces  delusion  persistence  in  spite
of  evidence  against  it,  sustained  also  by  the  right  frontal
lobe.14 The  positive  mechanism  in  this  case  would  be  the
beliefs  evaluation  system,  similar  to  the  reality  monitoring
functions.15
On  the  other  hand,  psychiatric  manifestations  of  Parkin-
son’s  disease  are:  depression  and  anxiety.  Mood  disorders
are  probably  Parkinson’s  disease’s  most  frequent  symptoms,
so  much  that  they  may  precede  motor  symptoms  in  up  to
30%  of  cases.16
Signiﬁcant  depression  prevalence  presents  itself  in  more
than  double  the  number  of  patients  with  Parkinson’s  (37%)
than  what  is  normally  found  in  other  diseases  (18%).  Less
severe  forms  of  depression  are  more  frequent  than  major
depression,  however;  the  latter  occurs  in  5%  of  patients.
Despite  everything,  the  depressive  symptomatology  dis-
played  in  this  context  goes  beyond  the  simple  expected
reaction  caused  by  suffering  an  upsetting  disease  and  being
mostly  disabled  to  a  greater  or  lesser  degree.  Changes  in  the
serotoninergic  system  play  a  major  role,  a  link  with  nora-
drenergic  transmission,  based  on  the  presence  of  a  deﬁcit
of  noradrenergic  neurons  in  the  locus  coeruleus.  There  is
a  dopamine  deﬁcit  in  mesocortic-limbic  projections  and  of
dopaminergic  cells  in  the  ventral  tegmentum  in  depressed
parkinsonians.17
The  anxiety  disorders  are  manifested  through  agitation,
chronic  anxiety,  panic  attacks  and  obsessive-compulsive
disorders.  The  pathogeny  of  anxiety  is  explained  by  the
increment  caused  by  levodopa  of  the  catecholamine  and  its
metabolites  of  the  brain.  It  is  usually  linked  to  the  amount
1isease  51
nd  duration  of  treatment  and  it  is  more  frequent  in  the
‘off’’  periods.18
Chronic  anxiety  can  be  an  exclusive  manifestation  of  the
‘off’’  periods  and  may  be  present  during  the  whole  day.
ue  to  therapeutic  implications,  it  is  important  to  deter-
ine  this  symptom’s  presentation  proﬁle,  because  in  the
ase  of  being  secondary  to  the  increment  of  catecholamine
y  levodopa,  dopaminergic  treatment  must  be  adjusted,  in
ddition  to  applying  psycho-pharmaceutics.19 Panic  attacks
re  usually  linked  to  prolonged  treatments  with  levodopa.
hey  constitute  a  rare  complication  and  occasionally  occur
n  concurrence  with  the  ‘‘off’’  periods  of  levodopa  depen-
ents,  much  later  than  dyskinesia  and  motor  ﬂuctuations.
In  this  case,  the  patient  has  presented  the  three  most
requent  types  of  psychiatric  manifestations,  although  what
raws  attention  has  been  the  Capgras  syndrome,  because
his  syndrome  constitutes  a  complex  process  that  is  not
imited  to  a  simple  facial  processing  problem,  but  a  mul-
iple  cerebral  dysfunction  which  sustains  it,  since  it  may
ecome  chronic.  Due  to  the  high  frequency  of  the  psychi-
tric  manifestations  of  Parkinson’s  disease,  linked  or  not  to
edical  treatment,  it  is  important  to  know  the  syndromes
ssociated  with  the  ‘‘off’’  periods  of  the  disease  and  to  know
ow  to  tell  them  apart  from  the  medications’  side  effects
nd  psychotic  symptoms  of  other  origin  in  order  to  imple-
ent  the  proper  treatment,  because  it  impacts  quality  of
ife  and  its  functional  prognosis.  Clinical  interviews  are  basic
or  establishing  the  order  of  the  symptoms.
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